$ICTSF Balance Sheet | Understand Stock

$ICTSF

$6.00 +$0.50 (9.09%) Close

$ICTSF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2011 As of Dec 31, 2011
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Restricted cash
Bank deposits
Term Deposits
Accounts receivable, net
Deferred tax assets, net
Income tax receivable
Receivable from a related party
Prepaid expenses and other current assets
Current assets from discontinued operations
Total current assets

Defered tax assets, net
Deferred tax assets, net
Investments
Deposits with customers
Restricted cash
Property and equipment, net
Non current assets from discontinued operations
Operating lease right of use assets
Goodwill
Other assets
Total assets

LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES:
Bank overdrafts
Financial institutions payable
Accounts payable
Accrued expenses and other current liabilities
Income tax payable
Value added tax (VAT) payable
Income tax and other taxes payable
Operating lease liabilities, current
Loan payable
Loan payable to related party, including accrued interest
Current liabilities from discontinued operations
Loan payable to related parties
Convertible notes payable to a related party
Total current liabilities

Liability to United States Department of Labor
Loan payable
Convertible notes payable to a related party
Operating lease liabilities, non-current
Other liabilities
Non current liabilities from discontinued operations
Total liabilities
REDEEMABLE NON-CONTROLLING INTERESTS
SHAREHOLDERS' DEFICIT:
Common stock, €0.01 and €0.45 par value as of December 31, 2025 and 2024; 150,000,000 shares authorized as of December 31, 2025 and 2024. 37,433,333 shares issued and outstanding as of December 31, 2025 and 2024.
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Treasury stock at cost (3,000,000 common stock as of December 31, 2025 and 2024)
Non-controlling interests in subsidiaries
Total shareholders' deficit
Total liabilities and shareholders' deficit

Comments